Difference between revisions of "Part:BBa K3140000"

 
(51 intermediate revisions by the same user not shown)
Line 3: Line 3:
 
<partinfo>BBa_K3140000 short</partinfo>
 
<partinfo>BBa_K3140000 short</partinfo>
  
PsiD is a tryptophan decarboxylase, which catalyses the conversion of L-tryptophan to tryptamine.
+
PsiD is a tryptophan decarboxylase that catalyses the conversion of L-tryptophan to tryptamine.
  
*[https://www.ncbi.nlm.nih.gov/protein/ASU62239.1 NCBI]
+
*NCBI: [https://www.ncbi.nlm.nih.gov/protein/ASU62239.1 ASU62239.1]
 
*UniProt: [https://www.uniprot.org/uniprot/P0DPA6 P0DPA6]
 
*UniProt: [https://www.uniprot.org/uniprot/P0DPA6 P0DPA6]
 
*EC number: [https://enzyme.expasy.org/EC/4.1.1.105 4.1.1.105]
 
*EC number: [https://enzyme.expasy.org/EC/4.1.1.105 4.1.1.105]
Line 11: Line 11:
 
===Usage and Biology===
 
===Usage and Biology===
  
PsiD is a native enzyme obtained from the ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine and 4-hydroxytryptamine, respectively. Heterologous expression of PsiD has been achieved in ''Escherichia coli'' <add strain> in a <expression system>.
+
The mechanism of psilocybin biosynthesis in ''Psilocybe'' sp. was recently elucidated by Fricke ''et al''.<ref name="Fricke">Fricke, J., Blei, F. & Hoffmeister, D. Enzymatic Synthesis of Psilocybin. ''Angew Chem Int Ed Engl'' '''56''', 12352-12355 (2017).</ref>, demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.
  
[[Image:T--Sydney_Australia--PsiD_KEGG_rxn1.gif|thumb|900px|Fig. 1: Decarboxylation of L-tryptophan to tryptamine, mediated by PsiD. Source: KEGG]]
+
PsiD is a native enzyme obtained from the ''Psilocybe cubensis'', which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine ('''Fig. 1''') and 4-hydroxytryptamine ('''Fig. 2'''), respectively. In a native state, PsiD is a 439 amino acid protein (49.6 kDa) with a theoretical pI of 5.44 calculated with the ExPASy ProtParam tool<ref name="ExPASy">Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. ''Nucleic Acids Res'' '''40''', W597-603 (2012).</ref>.
  
ADD:
+
[[Image:T--Sydney_Australia--PsiD_KEGG_rxn1.gif|frame|none|'''Fig. 1''': Decarboxylation of L-tryptophan to tryptamine, mediated by PsiD. CO<sub>2</sub> is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R00685 KEGG]  ]]
  
- SDS-PAGE IMAGE
+
[[Image:T--Sydney_Australia--PsiD_KEGG_rxn2.gif|frame|none|'''Fig. 2''': Decarboxylation of 4-hydroxy-L-tryptophan to 4-hydroxytryptamine, mediated by PsiD. CO<sub>2</sub> is released as a by-product. Source: [https://www.genome.jp/dbget-bin/www_bget?reaction+R11932 KEGG]  ]]
- LC/MS
+
- pUS250 and pET-28c(+)
+
  
<span class='h3bb'>Sequence and Features</span>
+
Heterologous expression of PsiD has been achieved in a T7 induction system using pET-28c(+) transformed into ''Escherichia coli'' BL21(DE3), co-transformed with chaperone plasmid pGro7 ('''Fig. 3'''), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa.
<partinfo>BBa_K3140000 SequenceAndFeatures</partinfo>
+
  
 +
[[Image:T--Sydney_Australia--PsiD_pET28c_map.png|700px|frame|none|'''Fig. 3''': pET-28c(+):PsiD plasmid map, showing C-terminal histidine tag, and T7 promoter under the control of the ''lac'' operator. Translated peptide is shown as the thin lime green arrow.]]
 +
 +
A band consistent with expression of PsiD in cells induced with IPTG was observed on polyacrylamide gel electrophoresis ('''Fig. 4''').
 +
 +
[[Image:T--Sydney Australia--SDS soluble PsiDKM.png|900px|thumb|none|'''Fig. 4''': Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced ''E. coli'' BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.]]
 +
 +
Activity of PsiD was confirmed with LC/MS. Protein extract from ''E. coli'' BL21(DE3) cells co-transformed with pET-28c(+):PsiD and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, tryptophan. The PsiD product, tryptamine, was only identified in the sample to which tryptophan was added, confirming the activity of PsiD ''in vitro'' ('''Fig. 5''').
 +
 +
[[Image:T--Sydney_Australia--PsiD%2Btryp_LCMS.png|frame|none|'''Fig. 5''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.]]
 +
 +
The presence of tryptophan in sample to which tryptophan was added may indicate autoxidation of tryptamine, as this compound was also observed in the mass spectrum of a 1 mM tryptamine standard ('''Table 1'''). However, neither hydroxytryptamine nor tryptamine was not observed in the sample to which tryptophan was not added ('''Table 2''').
 +
 +
{| class="wikitable"
 +
|+ ''Table 1'': Identified compounds in LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan.
 +
|-
 +
! Retention time (min)
 +
! Signal/noise ratio
 +
! Measured m/z
 +
! Formula
 +
! Ion identity
 +
|-
 +
| 3.67
 +
| 5.3
 +
| 177.1023
 +
| C10H13N2O
 +
| hydroxytryptamine
 +
|-
 +
| 4.91
 +
| 16.6
 +
| 205.0973
 +
| C11H13N2O2
 +
| tryptophan
 +
|-
 +
| 5.39
 +
| 17.8
 +
| 161.1074
 +
| C10H13N2
 +
| tryptamine
 +
|-
 +
| 10.12
 +
| 9.6
 +
| 285.1336
 +
| C14H21O6
 +
| unknown
 +
|-
 +
| 10.12
 +
| 9.6
 +
| 285.1336
 +
| C9H18N8OP
 +
| unknown
 +
|}
 +
 +
{| class="wikitable"
 +
|+ ''Table 2'': Identified compounds in LC/MS of protein extract of ''E. coli'' BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, without the addition of tryptophan.
 +
|-
 +
! Retention time (min)
 +
! Signal/noise ratio
 +
! Measured m/z
 +
! Formula
 +
! Ion identity
 +
|-
 +
| 10.15
 +
| 10.3
 +
| 285.1336
 +
| C14H21O6
 +
| unknown
 +
|-
 +
| 10.15
 +
| 10.3
 +
| 285.1336
 +
| C9H18N8OP
 +
| unknown
 +
|}
 +
 +
''In vivo'' expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 ('''Fig. 6'''). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. ''E. coli'' DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.
 +
 +
[[Image:T--Sydney_Australia--pUS387_map.png|700px|frame|none|'''Fig. 6''': pUS387 plasmid map, showing PsiD, PsiK, and PsiM genes organised in a cluster, driven by a class 1 integron gene cassette Pc promoter, flanked by CuO, a cumate repressor binding operator.]]
 +
 +
{| class="wikitable"
 +
|+ ''Table 3'': Identified compounds in LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine.
 +
|-
 +
! Retention time (min)
 +
! Signal/noise ratio
 +
! Measured m/z
 +
! Formula
 +
! Ion identity
 +
|-
 +
| 0.56
 +
| 23.2
 +
| 271.0817
 +
| C12H15O7
 +
| unknown
 +
|-
 +
| 1.16
 +
| 12.4
 +
| 257.0689
 +
| C10H14N2O4P
 +
| norbaeocystin
 +
|-
 +
| 1.9
 +
| 0.9
 +
| 271.0844
 +
| C11H16N2O4P
 +
| baeocystin
 +
|-
 +
| 2.75
 +
| 5.2
 +
| 177.1023
 +
| C10H13N2O
 +
| hydroxytryptamine
 +
|-
 +
| 5.08
 +
| 6.4
 +
| 205.0972
 +
| C11H13N2O2
 +
| tryptophan
 +
|-
 +
| 5.82
 +
| 6.4
 +
| 161.1074
 +
| C10H13N2
 +
| tryptamine
 +
|-
 +
| 10.15
 +
| 14.4
 +
| 285.1335
 +
| C14H21O6
 +
| unknown
 +
|-
 +
| 10.15
 +
| 14.4
 +
| 285.1335
 +
| C9H18N8OP
 +
| unknown
 +
|}
 +
 +
The presence of tryptophan in LC/MS confirms the presence of endogenous tryptophan in ''E. coli''. As tryptophan was not added to these cultures, ''in vivo'' activity of PsiD is confirmed by observation of PsiD product tryptamine ('''Fig. 7''').
 +
 +
[[Image:T--Sydney_Australia--tryptamine16_387_lcms.png|frame|none|'''Fig. 7''': Mass spectra obtained LC/MS of protein extract of ''E. coli'' DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.]]
 +
 +
Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from ''Psilocybe cubensis'' in ''Escherichia coli'' both ''in vivo'' and ''in vitro''.
 +
 +
<span class='h3bb'>'''Sequence and Features'''</span>
 +
<partinfo>BBa_K3140000 SequenceAndFeatures</partinfo>
  
 
<!-- Uncomment this to enable Functional Parameter display  
 
<!-- Uncomment this to enable Functional Parameter display  
Line 29: Line 170:
 
<partinfo>BBa_K3140000 parameters</partinfo>
 
<partinfo>BBa_K3140000 parameters</partinfo>
 
<!-- -->
 
<!-- -->
 +
 +
===References===

Latest revision as of 08:45, 20 October 2019


PsiD - Tryptophan decarboxylase from Psilocybe cubensis

PsiD is a tryptophan decarboxylase that catalyses the conversion of L-tryptophan to tryptamine.

Usage and Biology

The mechanism of psilocybin biosynthesis in Psilocybe sp. was recently elucidated by Fricke et al.[1], demonstrating that L-tryptophan proceeds through decarboxylation (mediated by PsiD), hydroxylation (mediated by PsiH), phosphorylation (mediated by PsiK), and finally N,N-dimethylation (mediated by PsiM) to yield psilocybin.

PsiD is a native enzyme obtained from the Psilocybe cubensis, which is involved in the metabolic biosynthesis of psilocybin from tryptophan. It accepts both L-tryptophan and 4-hydroxy-L-tryptophan as substrates, producing tryptamine (Fig. 1) and 4-hydroxytryptamine (Fig. 2), respectively. In a native state, PsiD is a 439 amino acid protein (49.6 kDa) with a theoretical pI of 5.44 calculated with the ExPASy ProtParam tool[2].

Fig. 1: Decarboxylation of L-tryptophan to tryptamine, mediated by PsiD. CO2 is released as a by-product. Source: KEGG
Fig. 2: Decarboxylation of 4-hydroxy-L-tryptophan to 4-hydroxytryptamine, mediated by PsiD. CO2 is released as a by-product. Source: KEGG

Heterologous expression of PsiD has been achieved in a T7 induction system using pET-28c(+) transformed into Escherichia coli BL21(DE3), co-transformed with chaperone plasmid pGro7 (Fig. 3), resulting in a 475 amino acid polypeptide, with a computed molecular weight of 53.6 kDa.

Fig. 3: pET-28c(+):PsiD plasmid map, showing C-terminal histidine tag, and T7 promoter under the control of the lac operator. Translated peptide is shown as the thin lime green arrow.

A band consistent with expression of PsiD in cells induced with IPTG was observed on polyacrylamide gel electrophoresis (Fig. 4).

Fig. 4: Polyacrylamide gel electrophoresis image of soluble protein extract from uninduced and IPTG induced E. coli BL21(DE3)::pGro7 cells containing pET-28c(+):PsiD, pET-28c(+):PsiK, and pET-28c(+):PsiM, run on an Mini-PROTEAN® TGX Stain-Free™ precast gel (Bio-Rad) at 120V for 60 minutes.

Activity of PsiD was confirmed with LC/MS. Protein extract from E. coli BL21(DE3) cells co-transformed with pET-28c(+):PsiD and pGro7 was subject to LC/MS, both with and without the addition of the PsiD substrate, tryptophan. The PsiD product, tryptamine, was only identified in the sample to which tryptophan was added, confirming the activity of PsiD in vitro (Fig. 5).

Fig. 5: Mass spectra obtained LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.

The presence of tryptophan in sample to which tryptophan was added may indicate autoxidation of tryptamine, as this compound was also observed in the mass spectrum of a 1 mM tryptamine standard (Table 1). However, neither hydroxytryptamine nor tryptamine was not observed in the sample to which tryptophan was not added (Table 2).

Table 1: Identified compounds in LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, with the addition of tryptophan.
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
3.67 5.3 177.1023 C10H13N2O hydroxytryptamine
4.91 16.6 205.0973 C11H13N2O2 tryptophan
5.39 17.8 161.1074 C10H13N2 tryptamine
10.12 9.6 285.1336 C14H21O6 unknown
10.12 9.6 285.1336 C9H18N8OP unknown
Table 2: Identified compounds in LC/MS of protein extract of E. coli BL21(DE3) co-transformed with pET-28c(+):PsiD and pGro7, without the addition of tryptophan.
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
10.15 10.3 285.1336 C14H21O6 unknown
10.15 10.3 285.1336 C9H18N8OP unknown

In vivo expression of PsiD was also confirmed. PsiD, PsiK, and PsiM were cloned into a pUS250 backbone as a gene cluster using Golden Gate cloning, yielding pUS387 (Fig. 6). Expression in pUS387 is driven by a class 1 integron gene cassette Pc promoter controlled by a cumate induction system. E. coli DH5α cells co-transformed with pUS387 and pGro7 were cultured in terrific broth (TB) supplemented with 4-hydroxytryptamine. Whole cell culture was subject to LC/MS.

Fig. 6: pUS387 plasmid map, showing PsiD, PsiK, and PsiM genes organised in a cluster, driven by a class 1 integron gene cassette Pc promoter, flanked by CuO, a cumate repressor binding operator.
Table 3: Identified compounds in LC/MS of protein extract of E. coli DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine.
Retention time (min) Signal/noise ratio Measured m/z Formula Ion identity
0.56 23.2 271.0817 C12H15O7 unknown
1.16 12.4 257.0689 C10H14N2O4P norbaeocystin
1.9 0.9 271.0844 C11H16N2O4P baeocystin
2.75 5.2 177.1023 C10H13N2O hydroxytryptamine
5.08 6.4 205.0972 C11H13N2O2 tryptophan
5.82 6.4 161.1074 C10H13N2 tryptamine
10.15 14.4 285.1335 C14H21O6 unknown
10.15 14.4 285.1335 C9H18N8OP unknown

The presence of tryptophan in LC/MS confirms the presence of endogenous tryptophan in E. coli. As tryptophan was not added to these cultures, in vivo activity of PsiD is confirmed by observation of PsiD product tryptamine (Fig. 7).

Fig. 7: Mass spectra obtained LC/MS of protein extract of E. coli DH5α co-transformed with pUS387 and pGro7, with the addition of 4-hydroxytryptamine. A peak at m/z = 161.10732 with chemical formula C10H13N2 was identified, matching PsiD product tryptamine.

Given these results, we conclude that we have successfully expressed the tryptophan decarboxylase PsiD from Psilocybe cubensis in Escherichia coli both in vivo and in vitro.

Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


References

  1. Fricke, J., Blei, F. & Hoffmeister, D. Enzymatic Synthesis of Psilocybin. Angew Chem Int Ed Engl 56, 12352-12355 (2017).
  2. Artimo, P. et al. ExPASy: SIB bioinformatics resource portal. Nucleic Acids Res 40, W597-603 (2012).